A recent study describes direct binding between a γ γδ δ T-cell receptor and its ligand, T22, a non-classical class I major histocompatibility complex (MHC) molecule. A companion study, solving the crystal structure of T22, highlights the differences between this interaction and those of classical MHC molecules and α αβ β T cells. The vertebrate immune system includes three types of cells that use somatic gene rearrangement to produce genes encoding their defining surface receptors: B cells, αβ T cells, and the enigmatic γδ T cells. The first clue to the existence of γδ T cells came with the serendipitous isolation of the T-cell receptor γ chain, at a time when a third type of lymphocyte was not anticipated [1] . More recently, studies with knockout mice have explored nonredundant functions of γδ T cells, pertaining to immunoprotection, immunoregulation, and the maintenance of tissue integrity (reviewed in [2] ). Nonetheless, investigators are struggling to define mechanisms underlying these functions and to put them in context with the biology and pathology of the host. A clearer understanding of what γδ T cells recognise via the γδ T-cell receptor will help to achieve this goal.
The vertebrate immune system includes three types of cells that use somatic gene rearrangement to produce genes encoding their defining surface receptors: B cells, αβ T cells, and the enigmatic γδ T cells. The first clue to the existence of γδ T cells came with the serendipitous isolation of the T-cell receptor γ chain, at a time when a third type of lymphocyte was not anticipated [1] . More recently, studies with knockout mice have explored nonredundant functions of γδ T cells, pertaining to immunoprotection, immunoregulation, and the maintenance of tissue integrity (reviewed in [2] ). Nonetheless, investigators are struggling to define mechanisms underlying these functions and to put them in context with the biology and pathology of the host. A clearer understanding of what γδ T cells recognise via the γδ T-cell receptor will help to achieve this goal.
Unlike αβ T cells, γδ T cells are not restricted to engaging antigen in the context of a major histocompatibility complex (MHC) molecule. Do they therefore behave like B cells, directly recognising antigens of a diverse nature? Human and murine γδ T cells can be activated by a variety of molecules, including small, non-peptidic ligands and large, protein antigens, such as non-classical MHC class I molecules, also known as MHC class Ib molecules (reviewed in [2] ). However, no biochemical evidence had been reported for direct binding of antigen to the γδ T-cell receptor, that is until a recent disclosure by Chien and colleagues [3] . This group has demonstrated binding of the murine MHC class Ib molecule T22 to the G8 γδ T-cell receptor, and has identified a proportionately large population of γδ-expressing splenocytes specific for this antigen. An accompanying report by Wingren et al. [4] provides structural data for the T22 molecule and reveals how some γδ T cells might recognise their non-classical MHC class I ligands. Together, these papers provide an important foundation for understanding γδ T-cell interactions and the integrated immune response to infectious or noninfectious challenge.
The hypothesis that γδ T cells might react with MHC class Ib molecules was first proposed to account for their common localisation within epithelia, the peripheral blood, and throughout lymphoid tissue parenchyma, and for the fact that these cells are not concentrated in areas of diverse antigen sampling [5] . Consistent with this, γδ T-cell repertoires display limited combinatorial diversity, and the use of distinct variable (V) gene segments is associated with particular tissues. Human Vγ1-Vδ1-expressing T cells, commonly intestinal intraepithelial lymphocytes, have been shown to respond to the β 2 -microglobulin-independent MHC class Ib molecules MICA and MICB, which are induced by heat shock in gut epithelial cells and are upregulated in a variety of carcinomas [6] [7] [8] . Antibodies to the γδ T-cell receptor could block this activation and the consequent lysis of MICA-expressing cells. There was no evidence either for additional antigen presented by MICA/MICB, or for any electron-dense material associated with MICA/MICB in the crystal structure [9] . This contrasts with the presentation of peptides by classical MHC class Ia and MHC class II molecules and the presentation of lipids by CD1. These findings implicate a new role for MHC class Ib molecules, like MICA, as surface indicators of internal cell stress or transformation, rather than as antigen-presenting molecules.
Intriguingly, a more recent study [10] showed that the natural killer (NK) cell activating receptor NKG2D, expressed by a spectrum of cytotoxic cells including γδ T cells, can act as a receptor for MICA. It is therefore possible that MICA is co-engaged by the γδ T-cell receptor and NKG2D, akin to the co-engagement of MHC class Ia molecules by the αβ T-cell receptor and the CD8 co-receptor. Such proposals await direct biochemical evidence of MICA-γδ T-cell receptor binding. Nonetheless, the recent demonstration [3] of a murine γδ T-cell receptor binding directly to T22, a molecule that clearly shares some features with MICA, may suggest an emerging paradigm. Although a murine homologue of MICA/MICB has yet to be found, murine γδ T-cell clones G8 and KN6, which are specific for T22 (and the related molecule T10) of the H2-TL family, provide precedence for the recognition of inducible MHC class Ib molecules.
In order to examine the recognition of T22 by the G8 T-cell receptor, Chien and colleagues [3] generated biotinylated tetramers of bacterially produced T22 and demonstrated their direct binding to soluble G8 T-cell receptor produced in insect cells. The interaction seemingly requires no other molecules. Surface plasmon resonance demonstrated that the affinity of the interaction is high compared with interactions between the αβ T-cell receptor and peptide-MHC complexes. The association rate for the G8 T-cell receptor with T22 was also fast compared with αβ T-cell receptor interactions, while the dissociation rate was slow. This higher affinity interaction may compensate for the relative instability of T22 and T10 compared with MHC class Ia molecules [11] , allowing for the appropriate γδ T cell to 'catch' the transient signal. Furthermore, while half-maximal cytolytic activity can be induced in the αβ T-cell clone 2C by as few as five MHC-peptide complexes on the surface of a target cell [12] , the G8 clone requires more than 100 T10 molecules to be expressed on the target cell [11] , suggesting that the activation threshold of γδ T cells is higher than that of αβ T cells. This finding agrees with the notion that γδ T cells respond to increased levels of endogenous surface antigens, whereas αβ T cells need to be sensitive to the de novo presentation of small amounts of pathogenderived determinants.
The report by Wingren et al. [4] in the same issue of Science presented the crystal structure of T22 at 3.1 Å. Interestingly, T22 bears some resemblance to the preceding structure of MICA [9] , while both depart from the established MHC class Ia structure elucidated by Wiley and colleagues [13] : the three structures are compared in Figure 1 . For reference, the classical MHC class I fold consists of three extracellular immunoglobulin domains, a transmembrane domain and a short cytoplasmic domain. The two distal extracellular domains, α1 and α2, form a 'platform' that sits atop a 'stalk' comprising the α3 domain and contacts β 2 microglobulin (Figure 1b) . The α1 and α2 domains form the characteristic parallel α helices that contain the requisite T-cell receptor contact sites, as well as an eight-stranded β sheet that provides contact points for the peptide. The peptide-binding groove formed by the α helices and supported by the β-sheet floor is enclosed at both ends in MHC class Ia molecules, but is open in MHC class II molecules, consequently accommodating longer peptides. By comparison, both MICA and T22 show profound differences from classical MHC class I molecules in the α1 and α2 domains.
In MHC class Ia and most MHC class Ib molecules, a key residue in the α1 alpha helix, termed the 'latch residue', is typically a glycine, allowing a disulphide bond to form and produce a kink in the helix. In MICA, the glycine is commonly replaced by a valine, disrupting the disulphide bond. This disruption consequently flattens the α1 helix and displaces it, narrowing the groove to less than 10 Å and precluding peptide binding. In addition, the second helix in the α2 domain forms a disordered loop, creating a small, hydrophilic pocket. While small molecules may be able to fit in the pocket, there is as yet no evidence for Dispatch R283
Figure 1
Crystal structure of (a,d) T22 compared with (b,e) HLA-A2 and (c,f) MICA. The classical MHC class I fold, seen in HLA-A2 (b,e), consists of three α domains and β2 microglobulin (green). The α1 and α2 domains are critical for peptide binding and αβ T-cell recognition. They form two α helices (red) which rest on top of eight β strands (blue; labelled S1-S4 in the α1 and α2 domains), forming the peptide-binding groove. In T22 (a,d), the H1 helix of the α1 domain is missing entirely, and the H2a helix is truncated, revealing portions of the β-sheet floor that could be interaction sites for the γδ T-cell receptor. The binding groove is narrowed and does not bind peptide. (c) MICA (green) compared with HLA-B27 (blue and red) shows that, unlike MHC class Ia molecules and other MHC class Ib molecules described to date, including T22, the α1-α2 platform of MICA is inverted so that the 'binding groove' faces the MICA-expressing cell and the underside of the cell is accessible to interacting cells. (f) The H1 helix (yellow) of MICA is displaced, narrowing the peptide-binding groove to less than 10 Å, so that MICA does not bind peptide. (a,b,d,e) reproduced with permission from [4] , and (c,f) with permission from [9] .
this. Moreover, the α1-α2 platform is inverted so that the underside may be accessible to interacting cells, while the 'binding groove' orients towards the MICA-expressing cell. Although there is a high degree of MICA polymorphism, two conserved patches in the underside of the α1-α2 platform have been proposed as interaction sites for MICA receptors.
Previous experiments identified deletions and substitutions of α1 and α2 domain residues in T22 that correspond to essential contact sites for peptide in MHC class Ia molecules and suggested that, like MICA, T22 would not bind peptide. The crystal structure of T22 confirms that the classical peptide-binding groove is unoccupied and, as in MICA, the groove is narrowed to less than 10 Å. In addition, T22 has a markedly truncated helix in the α1 domain revealing part of the β-sheet floor. By comparing the T22 allelic variants that do not activate the G8 T-cell clone and mapping the non-conserved residues onto the structure, two acidic patches on the β-sheet floor are suggested as possible interaction sites for the G8 T-cell receptor.
Understandably, only co-crystallization of the G8 T-cell receptor with T22 will elucidate the precise nature of the contacts that lead to γδ T-cell activation. Important issues will then be resolved -for example, what are the respective roles of the γδ T-cell receptor complementarity determining regions (CDRs) 1, 2 and 3 in making specific contacts? The use of T22 tetramers has allowed Chien and colleagues [3] to estimate that between 0.3 and 0.6% of resting γδ-expressing splenocytes or intestinal intraepithelial lymphocytes react with T22, a population that theoretically may be large enough to encounter appropriate antigen stochastically in the periphery without the need for specialised antigen-sampling compartments. Further study will reveal the heterogeneity in T-cell receptor usage within the T22-reactive population.
The gene rearrangement paradigm emphasises the potential of junctional diversity to broaden the repertoire of B-cell and T-cell receptors via the creation of highly heterogeneous CDR3 domains. Theoretically, these regions of the T-cell receptor δ chain are extremely diverse, due to the usage of multiple Dδ gene segments, and are at least as diverse as those of immunoglobulin heavy chain [14] . Nonetheless, it is striking that the prevalent reactivities of γδ T cells segregate with T-cell receptor combinations. Thus, low molecular mass antigens are recognised by human Vγ2-Vδ2 receptors, while MICA is recognised by Vδ1-expressing cells. Moreover, the germline-encoded CDR1 and CDR2 domains are themselves diverse among different γδ T-cell receptors [2] .
These findings suggest that antigen reactivities of the γδ T-cell receptor might be predominantly determined by CDR1 or CDR2 sequences that are selected over generational time, rather than somatically. One of the defining features of the adaptive immune response is that somatic gene rearrangement confers on cells the capacity to generate entirely new receptors that are then subjected to positive and/or negative selection. Were γδ T-cell receptor reactivities to be in large part attributable to CDR1 or CDR2 domains, then the somatic rearrangement mechanism would have little capacity to generate better or worse receptors, and hence there would be no need for selection beyond an appropriate continuous open reading frame. From this viewpoint, γδ Τ cells would express germline-selected receptor pairs like the other cells of the innate immune system. The proportionately large population of cells with T22/T10 reactivity and the moderately high affinity of the γδ T-cell receptor for ligand is consistent with this, as is the currently tenuous evidence for a major contribution of junctional diversity to γδ T-cell specificity. (Figure 2 ). By incubating a new monoclonal antibody that recognises both T22 and T10 with cells from a T22-deficient mouse, Chien and colleagues [3] indicated that T10 expression can be induced on splenocytes by polyclonal stimuli, such as lipopolysaccharide and concanavalin A, or by specific antigen. Not only might this have significance for γδ T-cell-mediated clearance of infected lymphocytes with an activationinduced phenotype, but it also reveals the crosstalk between lymphocytes and potential mechanisms of immunoregulation by γδ T cells [2] .
T10 is characteristically upregulated on activated lymphocytes [15] and it is also known that γδ Τ cells kill activated Th2 cells [16] , thereby skewing immune responses toward a Th1 inflammatory or cytotoxic response. In some cases, as in Lyme disease [16] and murine models of myocarditis [17] , excessive antiviral Th1 response has deleterious results for the host. In other cases, for example in young animals where Th2 responses dominate, γδ T-cell-mediated killing of Th2 cells may be highly favourable [2] . Perhaps even some allergy sufferers owe their grief to downregulated or deficient T10-reactive γδ Τ cells resulting in a bias towards what may be a default Th2 response. A deeper examination of T10-reactive γδ Τ cells, now made possible, may lead to the development of specific agonists or inhibitors and indicate potential new avenues of therapy for diseases of immune dysregulation.
A further question relates to how T10/T22-expressing cells are 'visualised' by γδ T cells. Are T10/T22-reactive cells primed by antigen in the periphery? Do the cells respond to it by virtue of co-engagement of a co-receptor, as hypothesised for the recognition of MICA by the γδ T-cell receptor and NKG2D? In the absence of such 'co-engagement', γδ T cells might not be fully activated, perhaps providing a mechanism for peripheral tolerance of an inherently autoreactive repertoire. Moreover, are these rules generally applicable to all γδ T cells or do the other 99.4% of γδ Τ cells recognise other, diverse antigens encoded by various pathogens, for example glycoprotein I encoded by herpes simplex virus? Again, these issues relate to how a useful γδ T-cell receptor repertoire is generated, and how its capacity to recognise and effect function against self is regulated. Additionally, given their capacity to see autologous molecules expressed by 'stressed' cells, γδ Τ cells have been implicated in tumour surveillance. Hence, the improved understanding of recognition by γδ T cells promises to augment our knowledge in this burgeoning area.
Taken together, studies of MICA and T22 have provided ideas of what and how γδ T cells can 'see'. While there is much to be learned, this crucial molecular foundation is already yielding ideas of when and where γδ Τ cells may be activated. These results thereby allow a more informed discussion of γδ T cell effector functions and of how some non-classical MHC molecules fit into the context of an immune response.
